Proposed Data Collections Submitted for Public Comment and Recommendations, 11125-11126 [2012-4380]
Download as PDF
11125
Federal Register / Vol. 77, No. 37 / Friday, February 24, 2012 / Notices
ESTIMATED BURDEN TABLE
Number of
responses per
respondent
Number of
respondents
Projects
Average
hours per
response
Response
burden
QDRL Interviews ................................................................................................
Focus groups .....................................................................................................
9000
300
1
1
1
1.5
9000
450
Total ............................................................................................................
........................
........................
......................
9450
Kimberly Lane,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2012–4378 Filed 2–23–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–12–12ET]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Kimberly Lane, CDC
Reports Clearance Officer, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
months, and who have a child under age
5, in order to recruit 72 participants for
the focus groups. These focus groups
will be conducted in Atlanta, Georgia
(4) and San Diego, California (4).
Findings from the focus groups will
inform revisions to existing CDC
messages and materials, which will be
further tested in the second information
collection activity, the online survey.
Phase II research will include an online
survey to test the revised messages and
materials. This web survey will: (1)
Examine baseline awareness and
knowledge regarding CMV, (2) assess
baseline CMV prevention behaviors
prior to viewing CMV communication
interventions (factsheet and video), (3)
assess appeal and evaluate the impact of
CMV communication interventions on
their attitudes, beliefs, and behavioral
intentions regarding prevention
behaviors and (4) assess knowledge,
attitudes and behaviors pre- and postinterventions with a larger target
audience sample (N=500). We estimate
that we will screen 3,000 women in
order to recruit 500 respondents for the
online survey.
All survey responses (100%) will be
submitted through a secure survey Web
site established for this project. No
Information in Identifiable Form (IIF)
collected will be transmitted to CDC.
The only IIF being collected (respondent
name, address, and phone number) is to
be used by the focus group facilities to
screen potential respondents to
determine eligibility for the focus
groups. The total estimated annual
burden is 531 hours. There are no costs
to the respondents other than their time.
This request is submitted to obtain
OMB clearance for one year.
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Communications Research to Inform
Messages and Materials about
Cytomegalovirus (CMV)—NEW—
Prevention Research Branch, National
Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Cytomegalovirus (CMV) is the most
common congenital infection in the
U.S., causing disabilities in more than
5,500 children born each year (CDC,
2010). Disabilities related to congenital
CMV are more common than other wellknown childhood conditions, such as
Down syndrome, fetal alcohol
syndrome, and neural tube defects, and
can include hearing or vision loss,
mental retardation, psychomotor delays,
and speech and language impairment.
This is a multiphase communication
research study that will help inform
CDC’s development materials and
prevention messaging about congenital
CMV. The information collection
activities will consist of focus groups
and an online survey. First, we plan to
conduct 8 focus groups with 9
respondents each to identify potential
messaging frames for communicating
information about congenital CMV to
the target audiences and adopting CMV
preventive guidelines. We estimate that
we will screen 144 women between the
ages of 18–40 who are either pregnant
or plan to get pregnant in the next 12
srobinson on DSK4SPTVN1PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Phase I: Focus Groups
Women (age 18–40) .........................
VerDate Mar<15>2010
18:34 Feb 23, 2012
Participant Screener .........................
Demographic questionnaire .............
Informed consent form .....................
Jkt 226001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
144
72
72
E:\FR\FM\24FEN1.SGM
1
1
1
24FEN1
5/60
15/60
15/60
12
18
18
11126
Federal Register / Vol. 77, No. 37 / Friday, February 24, 2012 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Number of
respondents
Form name
Focus group .....................................
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
72
1
90/60
108
Phase II: Web Survey
Women (age 18–40) .........................
Participant screener .........................
Web Survey ......................................
3,000
500
1
1
5/60
15/60
250
125
Total ...........................................
...........................................................
........................
........................
........................
531
Kimberly S. Lane,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2012–4380 Filed 2–23–12; 8:45 am]
BILLING CODE 4163–18–P
Proposed Project
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day-12–0210]
srobinson on DSK4SPTVN1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Kimberly Lane, CDC
Reports Clearance Officer, 1600 Clifton
Road, MS D–74, Atlanta, GA 30333 or
send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
VerDate Mar<15>2010
18:34 Feb 23, 2012
Jkt 226001
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
List of Ingredients Added to Tobacco
in the Manufacture of Cigarette
Products—Extension—Office on
Smoking and Health, National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Cigarette smoking is the leading
preventable cause of premature death
and disability in the United States. Each
year, more than 440,000 premature
deaths occur as the result of diseases
related to cigarette smoking. The
Centers for Disease Control and
Prevention (CDC), Office on Smoking
and Health (OSH) has the primary
responsibility for the Department of
Health and Human Services (HHS)
smoking and health program. HHS’s
overall goal is to reduce death and
disability resulting from cigarette
smoking and other forms of tobacco use
through programs of information,
education and research.
The Comprehensive Smoking
Education Act of 1984 (CSEA, 15 U.S.C.
1336 or Pub. L. 98–474) requires each
person who manufactures, packages, or
imports cigarettes to provide the
Secretary of Health and Human Services
(HHS) with a list of ingredients added
to tobacco in the manufacture of
cigarettes. The legislation also
authorizes HHS to undertake research,
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
and to report to the Congress (as deemed
appropriate) discussing the health
effects of these ingredients.
HHS has delegated responsibility for
implementing the CSEA’s ingredient
reporting requirements to CDC’s Office
on Smoking and Health (OSH). OSH has
collected ingredient reports on cigarette
products since 1986. Respondents are
commercial cigarette manufacturers,
packagers, or importers, or their
designated representatives. Respondents
are not required to submit specific
forms, however, they are required to
submit a list of all ingredients used in
their products. CDC requires the
ingredient report to be submitted by
chemical name and Chemical Abstract
Service (CAS) Registration Number,
consistent with accepted reporting
practices for other companies currently
required to report ingredients added to
other consumer products. Typically,
respondents submit a summary report to
CDC with the ingredient information for
multiple products, or a statement that
there are no changes to their previously
submitted ingredient report. The
estimated burden per response is 6.5
hours.
Ingredient reports for new products
are due at the time of first importation.
Thereafter, ingredient reports are due
annually on March 31. Information is
submitted to OSH by mailing a written
report on the respondent’s letterhead, by
CD, three-inch floppy disk, or thumb
drive. Electronic mail submissions are
not accepted. Upon receipt and
verification of the annual ingredient
report, OSH issues a Certificate of
Compliance to the respondent.
There are no costs to respondents
other than their time.
E:\FR\FM\24FEN1.SGM
24FEN1
Agencies
[Federal Register Volume 77, Number 37 (Friday, February 24, 2012)]
[Notices]
[Pages 11125-11126]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-4380]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-12-12ET]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570
and send comments to Kimberly Lane, CDC Reports Clearance Officer, 1600
Clifton Road, MS-D74, Atlanta, GA 30333 or send an email to
omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Communications Research to Inform Messages and Materials about
Cytomegalovirus (CMV)--NEW--Prevention Research Branch, National Center
on Birth Defects and Developmental Disabilities (NCBDDD), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Cytomegalovirus (CMV) is the most common congenital infection in
the U.S., causing disabilities in more than 5,500 children born each
year (CDC, 2010). Disabilities related to congenital CMV are more
common than other well-known childhood conditions, such as Down
syndrome, fetal alcohol syndrome, and neural tube defects, and can
include hearing or vision loss, mental retardation, psychomotor delays,
and speech and language impairment.
This is a multiphase communication research study that will help
inform CDC's development materials and prevention messaging about
congenital CMV. The information collection activities will consist of
focus groups and an online survey. First, we plan to conduct 8 focus
groups with 9 respondents each to identify potential messaging frames
for communicating information about congenital CMV to the target
audiences and adopting CMV preventive guidelines. We estimate that we
will screen 144 women between the ages of 18-40 who are either pregnant
or plan to get pregnant in the next 12 months, and who have a child
under age 5, in order to recruit 72 participants for the focus groups.
These focus groups will be conducted in Atlanta, Georgia (4) and San
Diego, California (4). Findings from the focus groups will inform
revisions to existing CDC messages and materials, which will be further
tested in the second information collection activity, the online
survey. Phase II research will include an online survey to test the
revised messages and materials. This web survey will: (1) Examine
baseline awareness and knowledge regarding CMV, (2) assess baseline CMV
prevention behaviors prior to viewing CMV communication interventions
(factsheet and video), (3) assess appeal and evaluate the impact of CMV
communication interventions on their attitudes, beliefs, and behavioral
intentions regarding prevention behaviors and (4) assess knowledge,
attitudes and behaviors pre- and post- interventions with a larger
target audience sample (N=500). We estimate that we will screen 3,000
women in order to recruit 500 respondents for the online survey.
All survey responses (100%) will be submitted through a secure
survey Web site established for this project. No Information in
Identifiable Form (IIF) collected will be transmitted to CDC. The only
IIF being collected (respondent name, address, and phone number) is to
be used by the focus group facilities to screen potential respondents
to determine eligibility for the focus groups. The total estimated
annual burden is 531 hours. There are no costs to the respondents other
than their time.
This request is submitted to obtain OMB clearance for one year.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Phase I: Focus Groups
----------------------------------------------------------------------------------------------------------------
Women (age 18-40)............. Participant 144 1 5/60 12
Screener.
Demographic 72 1 15/60 18
questionnaire.
Informed consent 72 1 15/60 18
form.
[[Page 11126]]
Focus group..... 72 1 90/60 108
----------------------------------------------------------------------------------------------------------------
Phase II: Web Survey
----------------------------------------------------------------------------------------------------------------
Women (age 18-40)............. Participant 3,000 1 5/60 250
screener.
Web Survey...... 500 1 15/60 125
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 531
----------------------------------------------------------------------------------------------------------------
Kimberly S. Lane,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2012-4380 Filed 2-23-12; 8:45 am]
BILLING CODE 4163-18-P